AllianceBernstein
BCEL

AllianceBernstein’s Atreca, Inc. Class A Common Stock BCEL Stock Holding History

AllianceBernstein’s Portfolio BCEL Stock Details BCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-12,600
Closed -$40K – 3421
2022
Q1 		$40K Sell
12,600
-10,400
-45% -$25.2K ﹤0.01% 3191
2021
Q4 		$70K Sell
23,000
-4,100
-15% -$19.1K ﹤0.01% 3224
2021
Q3 		$169K Hold
27,100
– – ﹤0.01% 3118
2021
Q2 		$231K Buy
27,100
+6,200
+30% +$63.5K ﹤0.01% 3112
2021
Q1 		$320K Sell
20,900
-2,400
-10% -$39K ﹤0.01% 2873
2020
Q4 		$376K Buy
23,300
+1,500
+7% +$22.5K ﹤0.01% 2738
2020
Q3 		$305K Sell
21,800
-600
-3% -$8.95K ﹤0.01% 2803
2020
Q2 		$477K Buy
22,400
+8,300
+59% +$147K ﹤0.01% 2644
2020
Q1 		$233K Buy
+14,100
New +$256K ﹤0.01% 2734

Other funds holding BCEL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LCM
Laurion Capital Management New York $1.07B AUM 75.73% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return